Bioworld Financial Watch articles from July 2007

Bioworld Financial Watch archives from July 2007

Gambler Cypress' bet pays; Pfizer approval good news.(Cypress Bioscience Inc.)
July 2, 2007... Pfizer Inc.'s approval by the FDA of Lyrica (pregabalin) for fibromyalgia turned more investor eyes to Cypress Bioscience Inc., which lately reaped the benefits of positive Phase III news with its compound for the condition, milnacipran. ...

Correction.(Correction notice)
July 2, 2007... In the Clinical Trials update in the June 18 issue of BioWorld Financial Watch, the description of Cell Genesys Inc.'s GVAX was incorrect. GVAX is immunotherapy comprised of a single leukemia cancer cell line modified to secrete GM-CSF.

Collaborations between biotech and pharmaceutical companies: May 25-June 28, 2007.
July 2, 2007... Biotech Co.* Pharma Co. (Country; Symbol) (Country) Type/Product Area Adenosine Novartis AG Option agreement for the A2B Therapeutics LLC* (Switzerland) receptor antagonist program, ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: May 25-June 28, 2007.
July 2, 2007... Biotech Co.* (Country; Symbol) Pharma Co. (Country) Type/Product Area AMDL Inc. YunNan KunMing Agreement to distribute (AMEX:ADL) YuSi Pharmaceutical levofloxacin Co. Ltd. (China)...

Biotech--big Pharma collaborations: modified and terminated agreements, May 25-June 28, 2007.
July 2, 2007... I. MODIFIED AGREEMENTS Biotech Co.* (Country; Symbol) Pharma Co. (Country) Change from original agreement Bio-Rad Beckman Coulter Inc. Extended for eight years their Laboratories ...

BioWorld stock report for public biotechnology companies.(Statistical table)
July 2, 2007... Close Close % Change Vol Company Symbol 6/22 6/29 WK YTD (000) Aastrom Biosci ASTM 1.37 1.35 -1.46% 9.76% 2608 Acadia Pharma ACAD ...

Cytokinetics' cancer bid iffy, heart effort showing promise.(Broad Program, Mixed Results)(Cytokinetics Inc.)(Table)
July 9, 2007... Casting a wide clinical net has its drawbacks--cost, mainly--and its advantages, such as better chances of finding efficacy. But even the positive point isn't always entirely so, as Cytokinetics Inc. found out late last month, when its good/bad...

Public financing of biotechnology: June 2007.(Table)
July 9, 2007... I. COMMENCED TRADING IN JUNE Company Date Date Shares/ Shares Out (Symbol) (#) Filed Comm. Units (M) Price (M) (@) INITIAL OFFERINGS Amsterdam 6/6/07 6/20/07 5S ...

Other financings of public biotechnology companies: June 2007.(Table)
July 9, 2007... TOTAL: $1,956.83M Number Company Type Of Of Shares, Units (Symbol) (#) Financing Or Warrants (M) Amount Raised (M) Acusphere Inc. Registered 7.7U ...

Venture capital and other investments in private biotechnology companies: June 2007.(Table)
July 9, 2007... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $447.175M Company Location Date Amt. (M) 7TM Pharma A/S Horsholm, Denmark 6/7 DKK123 ($22.2) Adenosine Charlottesville, 6/18 ...

Milestone payments and investments from corporate partners: June 2007.(Table)
July 9, 2007... TOTAL: $57.375M Year to Date: $467.05M Company (Symbol) (#*) Partner (Country) Amt. (M) Triggering Event Ablynx* (Belgium) Procter & Gamble Co. ND Milestone ...

Money raised by biotech in 2007: January-June.(Table)(Brief article)
July 9, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.(Table)
July 9, 2007... Close Close %Change Vol Company Symbol 6/29 7/6 WK YTD (000) Aastrom Biosci ASTM 1.35 1.32 -2.22% 7.32% 2006 Acadia Pharma ACAD ...

Santarus' Zegerid for GERD: PPI plus antacid the ticket?(Santarus Inc.)(gastroesophageal reflux disease)(proton pump inhibitor)(Table)
July 16, 2007... "GERD" might sound like the nickname of the nice German lady down the block who bakes Pfeffernusse cookies at Christmas, but physicians, biotech firms and a large number of unhappy patients know GERD as the acronym for gastroesophageal reflux...

Clinical trials update: June 2007.(Table)
July 16, 2007... Company* (Country; Symbol) Product Description Indication AUTOIMMUNE Abbott Humira Adalimumab; a tumor Rheumatoid Laboratories (FDA-n necrosis factor arthritis...

American society of clinical oncology (ASCO) clinical trials news: June 2007.(Table)
July 16, 2007... Company* (Country; Symbol) Product Description CANCER Abraxis BioScience Abraxane (FDA- Paclitaxel protein-bound particles Inc. (ABBI) approved) for injectable suspension Abraxis BioScience...

Non-U.S. clinical trials and regulatory actions: June 2007.(United States)(Table)
July 16, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Abbott Humira (FDA- Adalimumab; tumor necrosis factor-alpha Laboratories approved) blocker agonist (NYSE:ABT) Centocor Inc. Remicade...

FDA submissions, approvals and other actions: June 2007.(Food and Drug Administration)(Table)
July 16, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Aspreva CellCept Mycophenolate mofetil; an Pharmaceuticals immunosuppressant Corp. (Canada; ASPV) CANCER Cel-Sci Corp....

BioWorld stock report for public biotechnology companies.(Table)
July 16, 2007... Close Close % Change Company Symbol 7/6 7/13 WK YTD Vol (000) Aastrom Biosci ASTM 1.32 1.34 1.52 8.94 2959 Acadia Pharma ACAD 13.76 13.7 ...

Telomerase, stem cells bids: Geron's profile grows higher.(Risks, But Maybe Big Rewards)
July 23, 2007... Geron Corp.'s steady news trickle this summer presages a stronger flow as the year goes on, and an "analyst day" last week got a hosted peek into what's ahead next year, leaving Geron watchers optimistic but reservedly so. The summer so...

Biotech mergers and acquisitions: April 27 - July 19, 2007.
July 23, 2007... Biotech Mergers And Acquisitions: April 27 - July 19, 2007 # I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired Acquired By Or Date Announced Date Completed * (Country; Merged With * Symbol) (Country; ...

BioWorld stock report for public Biotechnology Companies.
July 23, 2007... Bioworld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 7/13 7/20 WK YTD (000) Aastrom Biosci ASTM 1.34 1.3...

EPO market shaken by CMS' plans to cut reimbursements.(Is Natural Erythropoietin Bad, Too?)
July 30, 2007... Investor jitters eased somewhat as the Centers for Medicare & Medicaid Services' plans for reimbursement of erythropoietin (EPO) stimulating agents (ESAs) became clearer, and backers of Amgen Inc. found cause for encouragement on two fronts....

Grants, contracts and awards to Biotech companies: March 22-July 26, 2007.
July 30, 2007... Grants, Contracts and Awards to Biotech Companies: March 22-July 26, 2007 Company * Funding Amount (Country; Symbol) Institution (US$M) Accentia National $2.4...

BioWorld stock report for Public Biotechnology Companies.
July 30, 2007... Bioworld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 7/20 7/27 WK YTD (000) Aastrom Biosci ASTM 1.34 1.23...